The primary purposes of the corporation shall be to raise awareness about, promote diagnosis and treatment of, and help patients with kidney diseases, by: (1) creating and providing scientific, clinical, and educational materials, seminars, training, and other forms of medical education to medical professionals and the public; (2) conducting and providing infrastructure and other forms of support for patient registries, biomarker studies, and genomic research; and (3) collaborating with other charitable organizations exempt under Section 501(c)(3) of the Code focused on rare kidney diseases in furtherance of the foregoing purposes.
Reported officers (all unpaid)
No paid executives reported in 2023. Glomerular Disease Study and reported 5 unpaid officers and board members on its 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.